GENEVA, Sept. 7 -- KEZAR LIFE SCIENCES, INC. filed a patent application (US2026/016521) for “DOSING REGIMENS FOR ZETOMIPZOMIB”. With publication no. WO/2026/183140, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/5377
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....